ArticleExperimental and therapeutic medicine2016

Risk of tuberculosis during infliximab therapy for inflammatory bowel disease, rheumatoid arthritis, and spondyloarthropathy: A meta-analysis.

Qiang Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.